Delivery Order SPE2DB20D2104-SPE2DB23FR31T

Award Date 12/5/22
Potential Completion Date 12/6/22
Potential Value $21K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is for the delivery of Cosentyx 300 mg dose-2 pen syringes by Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to the Defense Logistics Agency (DLA). The $4,411.50 delivery order is under a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military and veterans' healthcare programs globally....
This federal contract award is for the delivery of Cosentyx, a 300mg dosage medication, to the Defense Logistics Agency (DLA). The $26,345.88 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary...
This federal contract award is for the delivery of Cosentyx 300 mg dose-2 pens to the Defense Logistics Agency (DLA). The $18,403.24 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 3, 2021 with a completion date of August 4, 2021. This contract is a child award under the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This federal contract award is for the delivery of Cosentyx 300 mg dose-2 pen injectors to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $1,521.95, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to...
This federal contract award is for the delivery of Cosentyx 300 mg dose-2 pen to the Defense Logistics Agency (DLA), a major component of the U.S. Department of Defense responsible for providing logistics support to the military. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a firm-fixed-price delivery order with a ceiling value of $5,972.52 and a completion date of December 30, 2021. The contract does not have a set-aside...
This federal contract award is for the delivery of Cosentyx 300 mg dose-2 pen subcutaneous injections to the Defense Logistics Agency (DLA), a component of the Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,106.01 and an ultimate completion date of December 22, 2021. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that...
This federal contract award is for the delivery of Cosentyx, a pharmaceutical medication, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $9,331.11 and is a firm fixed-price delivery order that runs through January 17, 2024. This award is part of a broader Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award is for the delivery of Cosentyx, a specialty medication, to the Defense Logistics Agency (DLA). The contract, valued at $6,234.28, has a period of performance through January 28, 2025. It was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award is for the delivery of Cosentyx 300 mg dose injectable medication to the Defense Logistics Agency (DLA) Troop Support Medical. The $4,485.09 firm fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of May 24, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of the pharmaceutical product Cosentyx 300 mg dose-2 pen to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The award was made to the prime contractor AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order valued at $22,250.85 with a firm fixed price and an ultimate completion date of September 20, 2021. AmerisourceBergen Drug Corp is a major pharmaceutical...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB23FR31T
    Delivery Order

This federal contract award is for the delivery of Cosentyx 300 mg dose-2 pen medication to the Defense Logistics Agency (DLA). The contract, valued at $20,655.64, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle for Cencora, Inc. to supply a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs. The contract does not have a set-aside designation, indicating full and open competition. The award demonstrates AmerisourceBergen's role as a key vendor for federal healthcare programs, particularly within the Department of Defense.

Generated 2/27/25, 10:37 AM